IL159890A0 - Dolastatin 10 derivatives - Google Patents

Dolastatin 10 derivatives

Info

Publication number
IL159890A0
IL159890A0 IL15989002A IL15989002A IL159890A0 IL 159890 A0 IL159890 A0 IL 159890A0 IL 15989002 A IL15989002 A IL 15989002A IL 15989002 A IL15989002 A IL 15989002A IL 159890 A0 IL159890 A0 IL 159890A0
Authority
IL
Israel
Prior art keywords
dolastatin
derivatives
Prior art date
Application number
IL15989002A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL159890A0 publication Critical patent/IL159890A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05Dipeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
IL15989002A 2001-07-19 2002-07-17 Dolastatin 10 derivatives IL159890A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01117410 2001-07-19
PCT/EP2002/007931 WO2003008378A1 (en) 2001-07-19 2002-07-17 Dolastatin 10 derivatives

Publications (1)

Publication Number Publication Date
IL159890A0 true IL159890A0 (en) 2004-06-20

Family

ID=8178073

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15989002A IL159890A0 (en) 2001-07-19 2002-07-17 Dolastatin 10 derivatives

Country Status (30)

Country Link
US (1) US6737409B2 (xx)
EP (1) EP1412328B1 (xx)
JP (1) JP2004534859A (xx)
KR (2) KR20060057652A (xx)
CN (1) CN1553897A (xx)
AR (1) AR036175A1 (xx)
AT (1) ATE341537T1 (xx)
BR (1) BR0211289A (xx)
CA (1) CA2453987A1 (xx)
CO (1) CO5550462A2 (xx)
DE (1) DE60215179T2 (xx)
DK (1) DK1412328T3 (xx)
ES (1) ES2272763T3 (xx)
GT (1) GT200200154A (xx)
HR (1) HRP20040043A2 (xx)
HU (1) HUP0401253A2 (xx)
IL (1) IL159890A0 (xx)
MX (1) MXPA04000577A (xx)
MY (1) MY127718A (xx)
NO (1) NO20040198L (xx)
NZ (1) NZ530655A (xx)
PA (1) PA8551001A1 (xx)
PE (1) PE20030258A1 (xx)
PL (1) PL367682A1 (xx)
PT (1) PT1412328E (xx)
RU (1) RU2296750C2 (xx)
SI (1) SI1412328T1 (xx)
UY (1) UY27388A1 (xx)
WO (1) WO2003008378A1 (xx)
ZA (1) ZA200400334B (xx)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7256257B2 (en) 2001-04-30 2007-08-14 Seattle Genetics, Inc. Pentapeptide compounds and uses related thereto
US7064211B2 (en) 2002-03-22 2006-06-20 Eisai Co., Ltd. Hemiasterlin derivatives and uses thereof
NZ535139A (en) * 2002-03-22 2007-07-27 Eisai Co Ltd Hemiasterlin derivatives and uses thereof in the treatment of cancer
EP2357006B1 (en) 2002-07-31 2015-09-16 Seattle Genetics, Inc. Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
BR122018071968B8 (pt) 2003-11-06 2021-07-27 Seattle Genetics Inc conjugado de anticorpo-droga, composição farmacêutica, artigo de manufatura e uso de um conjugado de anticorpo-droga
JP2008501653A (ja) * 2004-06-02 2008-01-24 エフ.ホフマン−ラ ロシュ アーゲー アミノ−アルコキシ−ヘプタン酸アルキルエステルの合成
EP3505191A1 (en) 2004-11-12 2019-07-03 Seattle Genetics, Inc. Auristatins having an aminobenzoic acid unit at the n terminus
BRPI0519023A2 (pt) * 2004-12-13 2008-12-23 Hoffmann La Roche composiÇço farmacÊutica contendo pelo menos um derivado de dolastatina 10
EP1828117A1 (en) * 2004-12-13 2007-09-05 F. Hoffmann-Roche AG Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
US20060161076A1 (en) * 2005-01-06 2006-07-20 Diamics, Inc. Systems and methods for collection of cell clusters
US20060189893A1 (en) * 2005-01-06 2006-08-24 Diamics, Inc. Systems and methods for detecting abnormal cells
CA2592969A1 (en) * 2005-01-13 2006-07-20 F. Hoffmann-La Roche Ag New one-step synthesis of useful disubstituted amines
JP4954983B2 (ja) 2005-05-18 2012-06-20 ファーマサイエンス・インコーポレイテッド Birドメイン結合化合物
WO2007008848A2 (en) 2005-07-07 2007-01-18 Seattle Genetics, Inc. Monomethylvaline compounds having phenylalanine carboxy modifications at the c-terminus
EP2722051B1 (en) 2005-07-07 2018-11-07 Seattle Genetics, Inc. Monomethylvaline compounds having phenylalanine side-chain modifications at the C-terminus
US7750116B1 (en) 2006-02-18 2010-07-06 Seattle Genetics, Inc. Antibody drug conjugate metabolites
CN101535300B (zh) 2006-05-16 2014-05-28 埃格拉医疗公司 Iap bir域结合化合物
US20080003652A1 (en) * 2006-06-28 2008-01-03 Hans Iding Novel enzymatic process for the manufacture of Boc-Dap-Oh priority to related application(s)
CA2692819A1 (en) 2007-07-16 2009-01-22 Genentech, Inc. Humanized anti-cd79b antibodies and immunoconjugates and methods of use
PE20140614A1 (es) 2007-07-16 2014-05-28 Genentech Inc Anticuerpos anti-cd79b e inmunoconjugados
SI2247620T1 (sl) 2008-01-31 2016-09-30 Genentech, Inc. Protitelesa proti CD79b in imunokonjugati in postopki za uporabo
EP2842575B1 (en) 2008-03-18 2017-09-27 Seattle Genetics, Inc. Auristatin drug linker conjugates
AU2011215900A1 (en) 2010-02-10 2012-07-26 Immunogen, Inc. CD20 antibodies and uses thereof
WO2011098904A1 (en) 2010-02-12 2011-08-18 Aegera Therapeutics, Inc. Iap bir domain binding compounds
EP2579887B1 (de) 2010-06-10 2014-11-12 Seattle Genetics, Inc. Neue auristatin-derivate und ihre verwendung
ES2553874T3 (es) 2010-09-29 2015-12-14 Seattle Genetics, Inc. N-Carboxialquil-auristatinas y su uso
CN103764667B (zh) * 2011-03-16 2017-06-20 西雅图基因公司 N‑羧烷基耳他汀类及其应用
EP3170821B1 (en) * 2011-05-27 2021-09-15 Ambrx, Inc. Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
JP6581774B2 (ja) 2011-05-27 2019-09-25 アンブルックス, インコーポレイテッドAmbrx, Inc. 非天然アミノ酸結合ドラスタチン誘導体を含有する化合物またはその化合物の溶媒和物、およびドラスタチンアナログを誘導体化するための方法
KR101520302B1 (ko) 2012-09-20 2015-05-15 (주)셀트리온 돌라스타틴 10 유도체, 그의 제조방법 및 그를 포함하는 항암제 조성물
ES2916722T3 (es) 2013-12-27 2022-07-05 Zymeworks Inc Sistemas de enlace que contienen sulfonamida para conjugados de fármacos
EP3689910A3 (en) 2014-09-23 2020-12-02 F. Hoffmann-La Roche AG Method of using anti-cd79b immunoconjugates
CN105949277B (zh) * 2015-05-05 2019-03-01 成都永泰诺科技有限公司 一种抗肿瘤化合物及其用途
ES2948846T3 (es) * 2016-03-29 2023-09-20 Toray Industries Derivado peptídico y uso del mismo
CN109021065B (zh) * 2017-06-08 2021-10-01 复旦大学 一种制备海兔毒素Dolastatin10的方法
WO2023033129A1 (ja) 2021-09-03 2023-03-09 東レ株式会社 癌の治療及び/又は予防用医薬組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323315B1 (en) 1999-09-10 2001-11-27 Basf Aktiengesellschaft Dolastatin peptides

Also Published As

Publication number Publication date
PL367682A1 (en) 2005-03-07
NO20040198L (no) 2004-02-19
JP2004534859A (ja) 2004-11-18
BR0211289A (pt) 2004-08-03
US6737409B2 (en) 2004-05-18
PE20030258A1 (es) 2003-03-19
PA8551001A1 (es) 2003-09-17
EP1412328A1 (en) 2004-04-28
US20030055002A1 (en) 2003-03-20
KR20060057652A (ko) 2006-05-26
MXPA04000577A (es) 2004-04-20
ATE341537T1 (de) 2006-10-15
DE60215179D1 (de) 2006-11-16
UY27388A1 (es) 2003-01-31
WO2003008378A1 (en) 2003-01-30
CA2453987A1 (en) 2003-01-30
KR20040023661A (ko) 2004-03-18
ZA200400334B (en) 2005-06-29
PT1412328E (pt) 2007-01-31
SI1412328T1 (sl) 2007-02-28
DE60215179T2 (de) 2007-10-18
ES2272763T3 (es) 2007-05-01
AR036175A1 (es) 2004-08-18
CN1553897A (zh) 2004-12-08
RU2296750C2 (ru) 2007-04-10
EP1412328B1 (en) 2006-10-04
HRP20040043A2 (en) 2004-08-31
KR100611540B1 (ko) 2006-08-10
GT200200154A (es) 2003-05-16
DK1412328T3 (da) 2007-02-12
NZ530655A (en) 2006-08-31
RU2004105145A (ru) 2005-07-10
CO5550462A2 (es) 2005-08-31
MY127718A (en) 2006-12-29
HUP0401253A2 (hu) 2004-12-28

Similar Documents

Publication Publication Date Title
IL159890A0 (en) Dolastatin 10 derivatives
TW595857U (en) 091219345
TW539393U (en) 089204149
HK1068608A1 (en) 3-Substituted-4-pyrimidone derivatives
HK1068607A1 (en) Phenylalkyloxy-phenyl derivatives
HUP0303186A3 (en) 4-aminobenzopyran derivatives
HUP0401949A3 (en) 4-imidazolin-2-one derivatives
HUP0500026A3 (en) N-heteroarylnicotinamide derivatives
GB0113342D0 (en) Novel Heterocycles 1
EP1392317A4 (en) SUBSTITUTED 1-BENZAZEPINE AND DERIVATIVES THEREOF
GB0113344D0 (en) Novel heterocycles 3
EP1364954A4 (en) Dicarba closo DODECARBORANDERIVATE
EP1364653A4 (en) CASOASE-3 INHIBITORS
GB0113343D0 (en) Novel Heterocycles 2
GB0104243D0 (en) Floodstoppers 2
AU2002361351A1 (en) 24 volt-battery device
GB0007203D0 (en) Supertrowel 2000
TW539394U (en) 090212946
GB0118917D0 (en) Biopower 3
GB0118315D0 (en) Jackit 31
GB0116704D0 (en) Unistore 800
TW539396U (en) 090220607
GB0118178D0 (en) July 24
GB0118177D0 (en) July 25
GB0125582D0 (en) Fotwear designs 4